Matthew T Plavan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew T Plavan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew T Plavan. Matthew T Plavan is Former CEO in CESCA THERAPEUTICS INC. ($KOOL) and Chief Executive Officer in Arcadia Biosciences, Inc. ($RKDA) and Chief Financial Officer in Arcadia Biosciences, Inc. ($RKDA).
Latest Insider Trading Transactions of Matthew T Plavan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Option Exercise | A | 3.05 | 250,000 | 762,500 | 435,450 | |
| Jan 25 2021 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Buy | P | 3.16 | 585 | 1,849 | 14,285 | 13.7 K to 14.3 K (+4.27 %) |
| Feb 04 2020 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Option Exercise | A | 4.91 | 76,000 | 373,160 | 185,450 | |
| Feb 04 2020 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Buy | P | 1.72 | 700 | 1,204 | 13,700 | 13 K to 13.7 K (+5.38 %) |
| Nov 18 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Buy | P | 4.08 | 1,000 | 4,080 | 13,000 | 12 K to 13 K (+8.33 %) |
| Sep 23 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Buy | P | 5.25 | 2,000 | 10,500 | 12,000 | 10 K to 12 K (+20.00 %) |
| Sep 10 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Buy | P | 6.52 | 1,000 | 6,521 | 10,000 | 9 K to 10 K (+11.11 %) |
| Sep 10 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Buy | P | 6.52 | 1,000 | 6,521 | 10,000 | 9 K to 10 K (+11.11 %) |
| Sep 10 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Buy | P | 6.49 | 1,000 | 6,493 | 9,000 | 8 K to 9 K (+12.50 %) |
| Sep 10 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Executive Off ... | Buy | P | 6.49 | 1,000 | 6,493 | 9,000 | 8 K to 9 K (+12.50 %) |
| Aug 28 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Grant | A | 6.88 | 1,000 | 6,880 | 8,000 | 7 K to 8 K (+14.29 %) |
| Aug 28 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Grant | A | 8.93 | 2,000 | 17,860 | 7,000 | 5 K to 7 K (+40.00 %) |
| Aug 28 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Grant | A | 8.95 | 1,000 | 8,950 | 5,000 | 4 K to 5 K (+25.00 %) |
| Aug 28 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Grant | A | 9.30 | 1,000 | 9,300 | 4,000 | 3 K to 4 K (+33.33 %) |
| Aug 28 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Grant | A | 9.32 | 1,000 | 9,320 | 3,000 | 2 K to 3 K (+50.00 %) |
| Aug 28 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Grant | A | 9.22 | 1,000 | 9,220 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Aug 28 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Grant | A | 8.33 | 1,000 | 8,330 | 1,000 | 0 to 1,000 |
| Jun 07 2019 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 5.04 | 26,000 | 131,040 | 109,450 | |
| Sep 20 2018 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 4.63 | 47,200 | 218,536 | 83,450 | |
| Sep 20 2018 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 4.63 | 47,200 | 218,536 | 83,450 | |
| Jun 09 2017 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 0.70 | 225,000 | 157,500 | 225,000 | |
| Sep 12 2016 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 15.00 | 37,500 | 562,500 | 37,500 | |
| Sep 12 2016 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 12.00 | 37,500 | 450,000 | 37,500 | |
| Sep 12 2016 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 8.00 | 150,000 | 1,200,000 | 150,000 | |
| Sep 12 2016 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 6.00 | 150,000 | 900,000 | 150,000 | |
| Sep 12 2016 | RKDA | Arcadia Bioscience ... | Plavan Matthew T | Chief Financial Off ... | Option Exercise | A | 2.17 | 125,000 | 271,250 | 125,000 | |
| Sep 04 2015 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | Former CEO | Sell | S | 0.69 | 5,871 | 4,036 | 245,066 | 250.9 K to 245.1 K (-2.34 %) |
| Sep 04 2015 | KOOL | CESCA THERAPEUTICS ... | Plavan Matthew T | Former CEO | Sell | S | 0.68 | 11,400 | 7,752 | 250,937 | 262.3 K to 250.9 K (-4.35 %) |
Page: 1